124 related articles for article (PubMed ID: 35503637)
1. Characterizing the critical role of metabolism in osteosarcoma based on establishing novel molecular subtypes.
Zhang WB; Han FM; Liu LM; Jin HB; Yuan XY; Shang HS
Eur Rev Med Pharmacol Sci; 2022 Apr; 26(8):2926-2943. PubMed ID: 35503637
[TBL] [Abstract][Full Text] [Related]
2. Machine learning survival prediction using tumor lipid metabolism genes for osteosarcoma.
Li S; Zheng Z; Wang B
Sci Rep; 2024 Jun; 14(1):12934. PubMed ID: 38839983
[TBL] [Abstract][Full Text] [Related]
3. Discovery of New Therapeutic Targets for Osteosarcoma Treatment Based on Immune-Related lncRNAs in the Tumor Microenvironment.
Fu R; Hong X
Biomed Res Int; 2022; 2022():3113857. PubMed ID: 35528175
[TBL] [Abstract][Full Text] [Related]
4. Identifying Molecular Subtypes and 6-Gene Prognostic Signature Based on Hypoxia for Optimizing Targeted Therapies in Non-Small Cell Lung Cancer.
Lin J; Chen S; Xiao L; Wang Z; Lin Y; Xu S
Int J Gen Med; 2022; 15():4417-4432. PubMed ID: 35509605
[TBL] [Abstract][Full Text] [Related]
5. Epithelial to Mesenchymal Transition Relevant Subtypes with Distinct Prognosis and Responses to Chemo- or Immunotherapies in Osteosarcoma.
Zhou Y; Li G; Li H; Lai F; Duan P; Cheng M
J Immunol Res; 2022; 2022():1377565. PubMed ID: 35836470
[TBL] [Abstract][Full Text] [Related]
6. Development and validation of apoptosis-related signature and molecular subtype to improve prognosis prediction in osteosarcoma patients.
Hong J; Li Q; Wang X; Li J; Ding W; Hu H; He L
J Clin Lab Anal; 2022 Jul; 36(7):e24501. PubMed ID: 35576501
[TBL] [Abstract][Full Text] [Related]
7. Construction of a 5-gene prognostic signature based on oxidative stress related genes for predicting prognosis in osteosarcoma.
Hong X; Fu R
PLoS One; 2023; 18(12):e0295364. PubMed ID: 38039294
[TBL] [Abstract][Full Text] [Related]
8. Identification of a 3-gene signature based on differentially expressed invasion genes related to cancer molecular subtypes to predict the prognosis of osteosarcoma patients.
Wan Y; Qu N; Yang Y; Ma J; Li Z; Zhang Z
Bioengineered; 2021 Dec; 12(1):5916-5931. PubMed ID: 34488541
[TBL] [Abstract][Full Text] [Related]
9. Exploring the relationship between metabolism and immune microenvironment in osteosarcoma based on metabolic pathways.
Wu C; Tan J; Shen H; Deng C; Kleber C; Osterhoff G; Schopow N
J Biomed Sci; 2024 Jan; 31(1):4. PubMed ID: 38212768
[TBL] [Abstract][Full Text] [Related]
10. Osteosarcoma subtypes based on platelet-related genes and tumor microenvironment characteristics.
Shu Y; Peng J; Feng Z; Hu K; Li T; Zhu P; Cheng T; Hao L
Front Oncol; 2022; 12():941724. PubMed ID: 36212395
[TBL] [Abstract][Full Text] [Related]
11. Molecular subtyping for lung adenocarcinoma and a novel prognostic model based on ligand-receptor pairs.
Li D; Ma X; Ou S
Adv Med Sci; 2022 Sep; 67(2):316-327. PubMed ID: 36054998
[TBL] [Abstract][Full Text] [Related]
12. Gene Expression Classifier Reveals Prognostic Osteosarcoma Microenvironment Molecular Subtypes.
Song YJ; Xu Y; Deng C; Zhu X; Fu J; Chen H; Lu J; Xu H; Song G; Tang Q; Wang J
Front Immunol; 2021; 12():623762. PubMed ID: 33959121
[TBL] [Abstract][Full Text] [Related]
13. Exploring a 7-gene prognostic model based on ferroptosis for efficiently guiding immunotherapy in melanoma patients.
Zhang X; Ding C; Zhao Z
Adv Med Sci; 2022 Sep; 67(2):364-378. PubMed ID: 36155341
[TBL] [Abstract][Full Text] [Related]
14. Molecular subtypes of osteosarcoma classified by cancer stem cell related genes define immunological cell infiltration and patient survival.
Guo L; Yan T; Guo W; Niu J; Wang W; Ren T; Huang Y; Xu J; Wang B
Front Immunol; 2022; 13():986785. PubMed ID: 36059448
[TBL] [Abstract][Full Text] [Related]
15. Identification of 9-Gene Epithelial-Mesenchymal Transition Related Signature of Osteosarcoma by Integrating Multi Cohorts.
Yiqi Z; Ziyun L; Qin F; Xingli W; Liyu Y
Technol Cancer Res Treat; 2020; 19():1533033820980769. PubMed ID: 33308057
[TBL] [Abstract][Full Text] [Related]
16. Identification of two immune subtypes in osteosarcoma based on immune gene sets.
Yang M; Cao Y; Wang Z; Zhang T; Hua Y; Cai Z
Int Immunopharmacol; 2021 Jul; 96():107799. PubMed ID: 34162161
[TBL] [Abstract][Full Text] [Related]
17. Expression of immune-related genes as prognostic biomarkers for the assessment of osteosarcoma clinical outcomes.
Guo J; Li X; Shen S; Wu X
Sci Rep; 2021 Dec; 11(1):24123. PubMed ID: 34916564
[TBL] [Abstract][Full Text] [Related]
18. Molecular characterization based on tumor microenvironment-related signatures for guiding immunotherapy and therapeutic resistance in lung adenocarcinoma.
Jie Y; Wu J; An D; Li M; He H; Wang D; Gu A; E M
Front Pharmacol; 2023; 14():1099927. PubMed ID: 36726580
[No Abstract] [Full Text] [Related]
19. Comprehensive analysis of prognostic tumor microenvironment-related genes in osteosarcoma patients.
Hu C; Liu C; Tian S; Wang Y; Shen R; Rao H; Li J; Yang X; Chen B; Ye L
BMC Cancer; 2020 Aug; 20(1):814. PubMed ID: 32854645
[TBL] [Abstract][Full Text] [Related]
20. A Four-Pseudogene Classifier Identified by Machine Learning Serves as a Novel Prognostic Marker for Survival of Osteosarcoma.
Liu F; Xing L; Zhang X; Zhang X
Genes (Basel); 2019 May; 10(6):. PubMed ID: 31146489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
